You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erdafitinib

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Healthy Trial in Merksem (Erdafitinib, Carbamazepine)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jul 14, 2022

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)

Not yet recruiting
  • Urinary Bladder Neoplasms
  • Receptors, Fibroblast Growth Factor
  • Erdafitinib Intravesical Delivery System
  • Kanagawa, Japan
  • +3 more
Jan 27, 2023

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Erdafitinib
  • Beijing, China
  • +5 more
Jan 31, 2023

Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

Recruiting
  • Bladder Cancer
  • +2 more
  • Erdafitinib
  • Basking Ridge, New Jersey
  • +6 more
Aug 22, 2022

Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

Recruiting
  • Bladder Carcinoma
  • +7 more
  • Atezolizumab
  • +5 more
  • Toronto, Ontario, Canada
    University Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Enfortumab Vedotin
  • Erdafitinib
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Recruiting
  • Bladder Cancer
  • +12 more
  • Raleigh, North Carolina
    xCures Virtual Site
Sep 20, 2021

Hepatic Impairment Trial in Kiel, Munchen (Erdafitinib)

Terminated
  • Hepatic Impairment
  • Erdafitinib
  • Kiel, Germany
  • +1 more
Mar 26, 2021

Lung Cancer, NSCLC, Pulmonary Tumor Trial in Germany (ERDAFITINIB)

Unknown status
  • Lung Cancer
  • +4 more
  • ERDAFITINIB
  • Gauting, Bavaria, Germany
  • +10 more
Nov 11, 2020

FGFR Testing by Either ctDNA Blood Testing or Standard Tumor

Recruiting
  • Metastatic Bladder Cancer
  • Metastatic Urothelial Carcinoma
  • FGFR Testing
  • Calgary, Alberta, Canada
  • +6 more
Nov 8, 2023

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

Recruiting
  • Advanced Solid Tumor
  • Erdafitinib
  • Tucson, Arizona
  • +199 more
Jan 27, 2023

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (JNJ-42756493 (erdafitinib))

Completed
  • Carcinoma, Hepatocellular
  • JNJ-42756493 (erdafitinib)
  • Changchun, China
  • +9 more
Feb 17, 2020

Multiple Myeloma, Relapsed/Refractory Trial in Toronto (JNJ-42756493, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Relapsed/Refractory
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 15, 2020

Urinary Bladder Tumors Trial in Worldwide (Erdafitinib, Investigator Choice (Gemcitabine), Investigator Choice (Mitomycin C))

Recruiting
  • Urinary Bladder Neoplasms
  • Erdafitinib
  • +2 more
  • Tucson, Arizona
  • +178 more
Mar 24, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Erdafitinib
  • +4 more
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Advanced Cancers and FGFR Genetic Alterations Trial (Erdafitinib)

Approved for marketing
  • Advanced Cancers and FGFR Genetic Alterations
  • Erdafitinib
  • (no location specified)
May 9, 2019

FGFR Gene Mutations in Tumor Tissue and Urine of Urothelial

Not yet recruiting
  • Bladder Cancer
  • FGFR test
  • (no location specified)
Apr 6, 2022

SOGUG-AVELUMAB_RWD

Recruiting
  • Metastatic Urothelial Carcinoma
  • Vigo, Pontevedra, Spain
  • +21 more
Jan 17, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Healthy Trial in Merksem (Erdafitinib, Fluconazole, Itraconazole)

Completed
  • Healthy
  • Erdafitinib
  • +2 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Sep 20, 2017